1. Wolf DM, Jordan VC: Gynecological complications associated with long-term adjuvant tamoxifen therapy for breast cancer. Gynecol Oncol 45: 118–128, 1992
2. Groom GC, Griffiths K: Effect of the anti-estrogen tamoxifen on plasma levels of luteinizing hormone, follicle stimulating hormone, prolactin, estradiol and progesterone in normal premenopausal women. J Endocrinol 70: 421–428, 1976
3. Manni A, Pearson OH: Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function. Cancer Treat Rep 64: 779–785, 1980
4. Ludwig Breast Cancer Study Group: A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. Cancer Res 45: 4454–4459, 1985
5. Sawka CA, Pritchard KI, Paterson DJA, Sutherland DJA, Thomson DB, Shalley WE, Myres RE, Mobbs BG, Malkin A, Meakin JW: Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast cancer. Cancer Res 46: 3152–3156, 1986